We were honored to welcome Sara Kappelmark Vice CEO of the Norrsken Foundation, to our Rwanda office. During her visit to Gynius Plus AB we had the privilege of showcasing our innovative and comprehensive solution to #cervicalcancer. Sara’s insightful feedback and enthusiastic support were both inspiring and motivating, reaffirming our mission to drive impactful change through innovation. Her visit highlighted the incredible potential of collaboration in addressing and tackling global health challenges. At Gynius, we remain dedicated to creating a future where cervical cancer is preventable and manageable for women around the world. Thank you, Sara, for your encouragement and belief in our work. Your support fuels our commitment to making a meaningful difference!
Gynius Plus AB
Tillverkning av medicintekniska produkter
Västra Frölunda, Vastra Gotaland County 855 följare
Striving to improve women's health around the world.
Om oss
Gynius was created in Sweden with the vision that our Flagship product would improve women’s healthcare around the world. We believed that this goal was achievable by making women’s healthcare affordable, simple and accessible. While our Swedish gynecologists realized that a portable colposcope could protect millions of women from cervical cancer and thus invented the Gynocular. After intensive research and development with clinical studies in Sweden, Bangladesh, and Uganda, the Gynocular was launched in the market. Gynius is a passion-driven company and we are very proud to have our device being used around the world in a variety settings and participating in new studies and applications. From December 2017, Gynius received the new management team and new owners with strong research background and also long time of international experiences. Gynius will continue to bring more R&D to our customers.
- Webbplats
-
http://www.gynius.se
Extern länk för Gynius Plus AB
- Bransch
- Tillverkning av medicintekniska produkter
- Företagsstorlek
- 11–50 anställda
- Huvudkontor
- Västra Frölunda, Vastra Gotaland County
- Typ
- Privatägt företag
Adresser
-
Primär
Järnbrotts Prästväg 2
Västra Frölunda, Vastra Gotaland County 421 47, SE
Anställda på Gynius Plus AB
-
Jacob Kuruvilla, PhD
Driving Bioscience Excellence | 10+ Years Expertise in -Omics Tech, Automation and Cutting-Edge Technologies | Dedicated to Elevating Research and…
-
Huaqing Li
CEO @ Gynius Plus AB | Life Science Expert
-
Joan UWAMAHORO
Project Manager| Experienced ICT & Administrative Professional| Aspiring Cybersecurity Specialist| Skilled in Data Management and Organizational…
-
Abeer Singh
Quality and Regulatory Manager
Uppdateringar
-
Gynius Plus AB omdelade detta
📢 We’re Hiring! IRCAD Africa is looking for a dedicated Head of Finance and Administration to join our mission of advancing minimally invasive surgical training and research. If you’re an experienced finance professional ready to lead and innovate, we’d love to hear from you! 📩 Send your CV to info@ircad.africa 🗓 Application Deadline: Open until filled Join us in shaping the future of surgical excellence in Africa! 🌍 #IRCADAfrica #Finance #Job #position
-
The Gynius team, led by CEO Dr. Huaqing Li, is dedicated to advancing global health solutions. From the introduction of Ambassador Dr. Diane Gashumba, Dr. Li anchored his first journey to Rwanda. The afterwards extensive travels between Sweden and Africa have highlighted the challenges faced in these regions. Under his observation and guidance, the team has developed the Gynius solution—a blend of a low-cost, high-capacity HPV testing platform and Gynocular telemedicine technology. This innovative approach allows for large-scale screening and "screen-and-treat" options to bolster cervical cancer initiatives. Along the journey, Gynius has been receiving so much help and support from different partners, such as Clinton Health Access Initiative, Inc., SPIDER , #SFH and Rwanda Biomedical Centre, #NRL, #PartnerinHealth, #FriendsofAfrica, #JhpiegoRwanda, etc. Gynius also offered the technical support to #ElektaFoundation for the last two years. Along the path to combat with cervical cancer, all the social care workers/volunteers and medical workers are the real heros in the frontline. Recognizing gaps in funding and accessibility, Dr. Li and the team have committed to donating one million free HPV testing tests as a leverage to support NGOs and governments in Africa. This initiative aims to enhance testing capacity and make a significant impact in the fight against cervical cancer. Organizations and governments interested in partnering with Gynius can reach out at info@gynius.se. Together, through collaboration and innovation, we can work towards eliminating cervical cancer and building a healthier future for all. #DigitalHealth #HealthcareInnovation #Somalia #ReproductiveHealth #Innovation #WHO #GlobalHealth #HealthEquity #GivingTuesday #HealthForAll #Jhpiegolmpact #Jhpiego #Parterinhealth #FriendsofAfrica #RBC #SFH #HealthForAll #CHAI #Mission2027 #CervicalCancerElimination #WomensHealth #PartnershipsForImpact #MedicaidCancerFoundation #CervicalCancerAwareness #WHOTarget2030 #CommunityHealth #AfricanHealth #FightCancer #CancerAwareness #HPVConference #CancerResearch #CancerDiagnostics #MedicalCommunity #Eurogin #HPVResearch #HPVCongress #HumanPapillomavirus #HPVScreening #HPVAwareness #CervicalCancerScreening #Triage #Papillomavirus #CancerStudies #Neoplasia #IARC #Läkarmissionen #LMInternational #Elekta #Epidemiology #HPVTesting #HPVVaccine #GlobalHälsa #Digitalisering #InnovationFörHälsa #UHC #SPIDERCenter #PrimaryHealthCare #HealthcareCapacityBuilding #Collaboration #HealthSystemStrengthening #EarlyDetection #Advocacy #StrongerTogether #2030Goals #AMR #Wisap UNICEF World Health Organization Clinton Health Access Initiative, Inc. Society of Gynecologic Oncology Technical University of Munich Rwanda Biomedical Centre American College of Obstetricians and Gynecologists (ACOG) Sexual Health Victoria Sabin Vaccine Institute Union for International Cancer Control (UICC) GroundSpeed Unitaid Expertise France AeHIN Secretariat
-
Gynius Plus AB omdelade detta
Today, on #WorldCervicalCancerDay, 🇸🇪 Sweden and 🇷🇼 Rwanda reaffirm our commitment to eliminating cervical cancer through vaccination, screening, and treatment. Together, we aim to achieve the WHO's 90-70-90 targets by 2030. Let's unite for a healthier future for all women! See below the joint statement by Hon Acko Ankarberg Johansson ,Swedish Minister of Health Care and Hon Sabin Nsanzimana, Rwandan Minister of Health. #cervicalCancerFreeFuture. #ActNow!
-
We are thrilled and honored to have participated in the #ZanzibarDigitalHealthSummit. It was an incredible opportunity to engage with leaders in health innovation, including representatives from the Ministry of Health and other key regional partners. Dr. Huaqing Li had the privilege of presenting Gynius Plus AB Solutions, highlighting the progress we’ve made in Rwanda to enhance cervical cancer screening using cutting-edge technology. During the session, Dr. Li also shared our exciting plans to expand these screening solutions to Zanzibar, aiming to improve early detection and increase accessibility to essential health services across the region. It was inspiring to witness firsthand the digital health initiatives being driven by the Zanzibar Ministry of Health. We firmly believe that improving healthcare and ensuring that no one is left behind can only be achieved through the power of digital innovation. We are grateful to be part of this important conversation and look forward to collaborating with the Ministry of Health and other stakeholders to create a lasting impact on healthcare in Zanzibar. #DigitalHealth #CervicalCancerScreening #HealthInnovation #Gynius #ZanzibarSummit #PublicHealth
-
Gynius Plus AB omdelade detta
#Gynocular by Gynius Plus AB is transforming cervical cancer screening with its portable, high-performance design and cutting-edge features. Here’s what sets it apart: Precision Lighting: The Gynocular’s integrated LED light source ensures consistent and optimal illumination. This brightness is essential for clear cervical exams, allowing healthcare professionals to detect abnormalities with confidence. Adjustable Intensity: Every exam is unique, and the Gynocular’s customizable light intensity meets the needs of various examination conditions. This flexibility enhances both patient comfort and diagnostic accuracy, giving clinicians the control they need. Advanced Optics: Equipped with a green filter and a warm, LED white light, the Gynocular provides highly accurate color rendering that resembles a bright halogen lamp. This setup brings out the fine details in cervical tissue, supporting precise and thorough examinations. Efficiency & Durability: Built to last, the LED technology minimizes the need for replacements, ensuring that the Gynocular is always ready for use – an invaluable feature for resource-limited settings. At Gynius Plus AB , our mission is to make advanced cervical cancer screening accessible worldwide. The Gynocular embodies this mission by being portable, affordable, and user-friendly – ideal for clinics, outreach programs, and healthcare settings where every examination can be life-saving. Let's bring light to healthcare innovation! 💡✨ #HealthcareInnovation #MedicalTechnology #CervicalCancerScreening #Gynocular #GyniusPlusAB #WomensHealth
-
We are thrilled to announce a strengthened partnership with Jhpiego Rwanda aimed at enhancing women-centered healthcare services! Together, we’re working to empower women by expanding access to essential screening for cervical and breast cancer in Rwanda. As the technical solution provider, Gynius Plus AB is proud to support Jhpiego’s mission by bringing innovative screening tools and solutions that make early detection more accessible and efficient. Through this collaboration, we aim to make a meaningful impact in the lives of women by prioritizing prevention and ensuring timely care. Together, we are paving the way for a healthier future for women, families, and communities. Here’s to a partnership rooted in innovation, impact, and empowerment! 💪 #GyniusPlusAB #JhpiegoRwanda #WomenCenteredHealthcare #CervicalCancerScreening #BreastCancerScreening #HealthcareInnovation
-
Welcome to join us in IPVC 2024 in Edinburgh and discuss with Dr. Jacob Kuruvilla from Gynius. #cervicalcancer #Eurogin2024 #HPVTesting
Driving Bioscience Excellence | 10+ Years Expertise in -Omics Tech, Automation and Cutting-Edge Technologies | Dedicated to Elevating Research and Innovation | Innovative sales strategies | Medical devices
🌍 Excited to be at IPVC 2024, representing Gynius Plus AB and engaging with global experts dedicated to HPV research and cervical cancer prevention! This is a unique opportunity to exchange ideas, stay up-to-date on the latest advancements, and contribute to the fight against cervical cancer. In addition to IPVC, we’re honored to participate in the WHO meeting, supporting the global mission for accessible and equitable cervical cancer screening worldwide. Together, we’re paving the way for better health outcomes and innovations that reach more people. I am available to discuss cervical cancer screening, prevention and treatment. The Gynius Solution’ provides an efficient, affordable, accessible and effective platform. Feel free to reach out to coordinate a meeting. Let’s work together towards better health outcomes! #CervicalCancerPrevention #Screening #HealthInnovation Grateful to be part of these vital conversations! #IPVC2024 #CervicalCancerPrevention #GyniusPlusAB #WHO #HealthInnovation #Gynocular
-
It was an honor to be featured in Näringsliv life science and to share Gynius Plus AB’s exciting journey. In 2024, we took a significant step forward by transitioning from being a single-device manufacturer to a comprehensive solution provider. Our breakthrough, the #Gynocular, the world’s first mobile and user-friendly colposcope, has been pivotal in improving women's health, particularly in low- to middle-income countries where access to cervical cancer screening is limited. Our mission has always been to make early detection of HPV and cervical cancer accessible, affordable, and effective. With the development of advanced HPV DNA testing methods, we can now process up to 4,000 samples a day using room-temperature storage, eliminating the need for costly, temperature-controlled facilities. This innovation, combined with our partnerships with non-profit organizations, is helping reduce cervical cancer mortality in regions like Africa, South America, and parts of Asia. At Gynius we are not only focused on detecting and diagnosing cervical cancer but also on predicting its future development, ensuring timely treatment and preventing further complications. As we continue to refine our technology and expand our global impact, we remain committed to making cervical cancer solutions standard practice worldwide and saving lives in the process. See more at: https://lnkd.in/df-TdeiA
-
🌍 At Gynius Plus AB, we're pushing the boundaries of accessible, high-quality diagnostics with a solution that combines precision, efficiency, and adaptability. Here’s a look at our latest innovation: 1️⃣ Color detection in self-sampling ensures immediate quality control, giving users confidence in the sample’s integrity. This feature minimizes the chances of error and the need for retesting. 2️⃣ Secure barcoding technology provides full traceability from collection to results, while maintaining strict confidentiality. Patients and providers can trust our system for reliable tracking. 3️⃣ Lyophilized reagents eliminate cold-chain storage requirements, keeping them stable at room temperature. This eases transport and storage, especially in resource-limited settings. 4️⃣ Automatic extraction system delivers rapid, consistent results without manual processing. This automation enhances speed and accuracy across testing workflows. 5️⃣ Broad compatibility with most qPCR machines allows for easy integration, saving setup time and adapting to existing lab environments. Users can plug in and start testing with minimal adjustments. 6️⃣ Minimal consumables per test reduce both cost and environmental impact, making it a sustainable choice. Efficient use of materials also makes it ideal for high-volume labs. 7️⃣ Affordable and validated for LMICs with rigorous quality standards, ensuring equity in healthcare. We’re committed to providing advanced diagnostics accessible to all. 8️⃣ High throughput of up to 4,000 tests per day meets large-scale testing demands effortlessly. This scalability is designed to support public health efforts worldwide. Watch our latest video to see how Gynius Plus AB is transforming diagnostics for a healthier future. #HealthcareInnovation #Diagnostics #GyniusPlusAB #GlobalHealth